|
Publications
> Recommendations of the ACIP
DTaP
Other
relevant MMWR publications
-
Dec
9, 2005, Vol 54, #RR-14
Recommended
Antimicrobial Agents for the Treatment and Postexposure Prophylaxis
of Pertussis: 2005 CDC Guidelines
-
Sep
26, 2003, Vol 52, #38
Notice
to Readers: FDA Approval of Diphtheria and Tetanus Toxoids and
Acellular Pertussis Vaccine Adsorbed, (INFANRIX®) for Fifth
Consecutive DTaP Vaccine Dose
-
Mar
14, 2003, Vol 52, #10
Notice
to Readers: FDA Licensure of Diphtheria and Tetanus
Toxoids and Acellular Pertussis Adsorbed, Hepatitis B
(Recombinant), and Poliovirus Vaccine Combined,
(PEDIARIX™) for Use in Infants
-
Jul
5, 2002, Vol 51, #26
Notice
to Readers: Food and Drug Administration Approval of a Fifth
Acellular Pertussis Vaccine for Use Among Infants and Young
Children -- United States, 2002
-
Nov
17, 2000, Vol 49, #RR-13
Use
of Diphtheria Toxoid-Tetanus Toxoid-Acellular Pertussis Vaccine
as a Five-Dose Series
Return to ACIP Page
|
|
This
page last modified on December 9, 2005 |
|
|
|